Docetaxel in the Treatment of Operable Breast Cancer: A Viewpoint by Etienne G.C. Brain

By Etienne G.C. Brain  

American Journal of Cancer, Vol. 3, Iss. 5, 2004-01 ,pp. : 333-334

Adis International

Access to resources Recommend Favorite

The curative role of radiotherapy in the treatment of operable breast cancer

By Kurtz J.   for the EUSOMA Working Party  

European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. : 1961-1974

Elsevier

Access to resources Recommend Favorite

Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer

By Fountzilas George   Pectasides Dimitrios   Christodoulou Christos   Timotheadou Eleni   Economopoulos Theofanis   Papakostas Pavlos   Papadimitriou Christos   Gogas Helen   Efstratiou Ioannis   Skarlos Dimosthenis  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 479-488

Humana Press, Inc

Access to resources Recommend Favorite

Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer

By Cooper Brenda   Radivoyevitch Tomas   Overmoyer Beth   Shenk Robert   Pham Huong   Samuels Judith   Parry Margaret   Silverman Paula  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 311-318

Springer Publishing Company

Access to resources Recommend Favorite

Comments on Inadequacy of Iridium Implant as Sole Radiation Treatment for Operable Breast Cancer

By Dale R.G.   Jones B.   Price P.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1707-1708

Elsevier

Access to resources Recommend Favorite